Reference Source

0409-1418-01 · Meperidine Hydrochloride Injection · Hospira, Inc., a Pfizer Company

What is the package ndc for 0409-1418-01 · Meperidine Hydrochloride Injection · Hospira, Inc., a Pfizer Company?

For 0409-1418-01 · Meperidine Hydrochloride Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-1418-01; generic name is Meperidine Hydrochloride Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-15.

"initial_posting_date": "05/30/2025", "package_ndc": "0409-1418-01", "generic_name": "Meperidine Hydrochloride Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Discontinuation of the manufacture of the drug"

api.fda.gov, retrieved 2026-09-01

Package NDC
0409-1418-01 verified
Generic name
Meperidine Hydrochloride Injection verified
Manufacturer
Hospira, Inc., a Pfizer Company verified
Status
Current verified
Availability now
Unavailable verified
FDA note
Discontinuation of the manufacture of the drug verified
Initial posting date
05/30/2025 verified
Last update date
08/24/2026 verified
Days in shortage
459 our reading
Reason for shortage
Discontinuation of the manufacture of the drug verified
Dosage form
Injection verified
Therapeutic category
Analgesia/Addiction verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category

"update_date": "08/24/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Demerol, Injection, 50 mg/1 mL (NDC 0409-1418-01)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Discontinuation of the manufacture of the drug", "status": "Current"

— all from api.fda.gov, retrieved 2026-09-01

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.